Top 10 Companies in the Medical Grade Epoxidized Soybean Oil Industry (2025): Market Leaders Driving Safer and Sustainable Medical Applications

In Business and finance, Global Business
September 25, 2025

The Global Medical Grade Epoxidized Soybean Oil Market was valued at USD 94 Million in 2023 and is projected to reach USD 120.52 Million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 2.80% during the forecast period (2023–2032). This growth is being driven by the rising demand for non-phthalate plasticizers in medical devices, stringent regulatory requirements for biocompatible materials, and the expanding use of bio-based stabilizers in healthcare packaging and PVC products for medical applications.

As the medical and pharmaceutical industries shift toward safer, more environmentally friendly materials, the focus turns to key manufacturers of medical-grade epoxidized soybean oil (ESBO). This versatile, non-toxic additive enhances the flexibility and stability of polymers used in everything from IV bags to surgical tubing. In this blog, we profile the Top 10 Companies in the Medical Grade Epoxidized Soybean Oil Industry—a blend of global chemical giants, specialized additives producers, and innovators in bio-based solutions who are pivotal in meeting the evolving needs of the healthcare sector.


🔟 1. Arkema

Headquarters: Colombes, France
Key Offering: Medical-grade ESBO for PVC stabilization, high-purity epoxidized oils compliant with USP and EP standards

Arkema stands as a frontrunner in the specialty chemicals arena, with its medical-grade ESBO products widely utilized in the production of flexible PVC for medical applications. The company’s expertise in polymer additives ensures that its ESBO variants meet rigorous purity levels required for direct contact with human tissues and fluids. Arkema’s commitment to innovation has led to advancements in processing techniques that improve the thermal stability and migration resistance of ESBO in medical tubing and films. Furthermore, their products are essential in reducing the environmental footprint of medical plastics by replacing traditional toxic plasticizers. With a global distribution network, Arkema supplies major medical device manufacturers, supporting the creation of safer healthcare solutions. Their R&D efforts focus on optimizing epoxidation processes to achieve higher oxirane oxygen content, ensuring superior performance in demanding medical environments.

Key Innovations:

  • Development of bio-based ESBO with enhanced biocompatibility

  • Partnerships with medical device firms for custom formulations

  • Investment in sustainable sourcing of soybean oil to meet green chemistry standards

Download FREE Sample Report: Medical Grade Epoxidized Soybean Oil Market – View in Detailed Research Report


9️⃣ 2. Galata Chemicals

Headquarters: Bristol, Pennsylvania, USA
Key Offering: High-purity ESBO grades for medical PVC, including oxirane oxygen variants at 6.2% and 6.8% min

Galata Chemicals has carved a niche in the production of organotin and epoxidized oil stabilizers, with a strong emphasis on medical-grade applications. Their ESBO products are engineered to provide excellent heat stability and clarity in PVC compounds used for medical packaging and devices. The company excels in delivering consistent quality that complies with FDA and REACH regulations, making it a preferred supplier for pharmaceutical packaging solutions. By leveraging advanced catalysis in the epoxidation process, Galata ensures low residual acidity and high epoxy values, which are critical for long-term performance in sterile medical environments. Their focus on customer-specific solutions has helped them expand in North American and European markets, where demand for safe plasticizers is surging due to health concerns over phthalates.

Key Innovations:

  • Proprietary purification methods for ultra-low impurity ESBO

  • Collaborations with regulatory bodies to certify medical-grade compliance


8️⃣ 3. CHS Inc.

Headquarters: Inver Grove Heights, Minnesota, USA
Key Offering: Renewable ESBO derived from agricultural sources, tailored for medical chemical products

As one of the largest farmer-owned cooperatives in the US, CHS Inc. brings a unique agricultural perspective to the ESBO market. Their medical-grade epoxidized soybean oil is produced from sustainably sourced soybeans, emphasizing traceability and eco-friendliness. This approach resonates with healthcare manufacturers seeking bio-based alternatives that align with circular economy principles. CHS’s ESBO is particularly valued in applications requiring non-toxic stabilization, such as flexible films for medical wraps and tubing. The company’s integrated supply chain from farm to formulation allows for cost-effective production while maintaining high standards of purity and consistency. Recent expansions in their refining capabilities have positioned CHS to meet the growing North American demand, driven by innovations in biodegradable medical plastics.

Key Innovations:

  • Integration of GMO-free soybean sources for premium medical applications

  • Scalable production targeting 100,000 tons annually by 2030


7️⃣ 4. Xinjinlong Chemical Additives

Headquarters: Heze, Shandong Province, China
Key Offering: Cost-effective medical-grade ESBO with high oxirane content for PVC and chemical stabilizers

Xinjinlong Chemical Additives is a prominent player in Asia’s chemical additives sector, specializing in ESBO production that meets international medical standards. Their facilities employ state-of-the-art epoxidation technology to produce clear, odorless oils suitable for sensitive medical uses like infusion bags and catheter materials. The company’s ability to scale production efficiently has made it a go-to supplier for global exporters in the medical device industry. By adhering to GMP (Good Manufacturing Practices), Xinjinlong ensures their products are free from harmful impurities, supporting the shift toward safer polymer formulations. Their strategic location in China’s agricultural heartland facilitates access to abundant soybean resources, keeping costs low without compromising quality.

Key Innovations:

  • Advanced R&D in hybrid epoxidation for improved yield and purity

  • Asia’s largest dedicated ESBO plant for medical applications

Download FREE Sample Report: Medical Grade Epoxidized Soybean Oil Market – View in Detailed Research Report


6️⃣ 5. Hairma Chemicals

Headquarters: Qingdao, China
Key Offering: ESBO variants for medical PVC products, focusing on low volatility and high thermal stability

Hairma Chemicals has established itself as a reliable provider of ESBO for the medical sector, with products that excel in enhancing the durability of PVC in healthcare settings. Their medical-grade offerings undergo rigorous testing to ensure biocompatibility, making them ideal for applications in blood bags and pharmaceutical packaging. The company’s emphasis on quality control and international certifications has enabled expansion into export markets, particularly in Europe and Asia-Pacific. Hairma’s innovative approaches include blending ESBO with other bio-additives to create multifunctional stabilizers that meet evolving regulatory demands. This positions them well in a market increasingly prioritizing patient safety and environmental sustainability.

Key Innovations:

  • Custom-blended ESBO for specific medical device requirements

  • Net-zero production goals through renewable energy in manufacturing


5️⃣ 6. Dongguan Lingchuang

Headquarters: Dongguan, Guangdong Province, China
Key Offering: High-purity ESBO for chemical and PVC medical applications, with 6.8% oxirane oxygen minimum

Dongguan Lingchuang specializes in fine chemicals, with a dedicated line for medical-grade ESBO that supports the production of flexible, non-toxic medical polymers. Their products are crucial in stabilizing PVC against degradation during sterilization processes, ensuring the integrity of medical equipment. The company’s proximity to major manufacturing hubs in China allows for just-in-time delivery, reducing supply chain disruptions for global medical firms. Lingchuang invests heavily in analytical testing to verify compliance with pharmacopeial standards, fostering trust among healthcare partners. As demand for localized production grows, their role in Asia-Pacific’s medical supply chain becomes increasingly vital.

Key Innovations:

  • Automated purification systems for consistent medical-grade quality

  • Expansion into hybrid bio-plasticizers for advanced medical uses


4️⃣ 7. Longda Oil Technology

Headquarters: Linyi, Shandong Province, China
Key Offering: Sustainable ESBO for medical chemical products, emphasizing non-toxic and bio-degradable properties

Longda Oil Technology leverages its expertise in vegetable oil processing to produce medical-grade ESBO that aligns with global sustainability goals. Their products are used in eco-friendly medical packaging, providing plasticizing effects without the risks associated with synthetic alternatives. The company’s integrated operations from soybean extraction to epoxidation ensure high purity and reliability. Longda’s focus on R&D has resulted in ESBO formulations with enhanced clarity and flexibility, ideal for transparent medical films. As regulations tighten on chemical safety, Longda’s commitment to transparent supply chains and third-party audits strengthens its market position.

Key Innovations:

  • Over 500,000 tons annual capacity, with medical-grade allocation growing

  • Collaborations for recyclable ESBO in medical waste reduction


3️⃣ 8. BASF SE

Headquarters: Ludwigshafen, Germany
Key Offering: Palatinol ESBO grades for medical PVC stabilization and chemical applications

BASF, a global leader in chemicals, offers medical-grade ESBO through its performance materials division, focusing on sustainable and safe polymer additives. Their ESBO products meet stringent EU medical device regulations, providing excellent stabilization for PVC in surgical and diagnostic equipment. BASF’s broad portfolio allows for seamless integration of ESBO in multi-component formulations, enhancing overall product performance. With a strong emphasis on circular economy principles, the company recycles production waste to minimize environmental impact. Their European headquarters facilitate close collaboration with medical innovators, driving advancements in bio-based materials for healthcare.

Key Innovations:

  • Bio-attributed ESBO from certified sustainable soybeans

  • Global supply partnerships for medical-grade consistency


2️⃣ 9. Dow Inc.

Headquarters: Midland, Michigan, USA
Key Offering: Medical-grade epoxidized oils for flexible PVC in healthcare, with high epoxy equivalents

Dow Inc. brings decades of experience in materials science to the ESBO market, producing medical-grade variants that ensure biocompatibility and processability in PVC extrusion for medical tubing. Their products are designed to withstand gamma and autoclave sterilization without compromising integrity. Dow’s innovation centers worldwide support customized ESBO solutions for specific medical needs, such as low-extractable formulations for implants. As a proponent of responsible chemistry, Dow invests in lifecycle assessments to promote the use of renewable feedstocks in medical applications, aligning with industry shifts toward greener practices.

Key Innovations:

  • Advanced analytics for impurity profiling in ESBO

  • Targeted expansion in sustainable processes for oils


1️⃣ 10. King Industries, Inc.

Headquarters: Norwalk, Connecticut, USA
Key Offering: Specialty ESBO for medical chemical products and PVC co-stabilizers

King Industries specializes in additives for coatings and plastics, with medical-grade ESBO that excels in providing secondary stabilization in healthcare PVC compounds. Their products are known for low odor and volatility, making them suitable for cleanroom environments in medical manufacturing. King’s technical support teams work closely with clients to optimize ESBO usage, improving efficiency and safety. The company’s focus on niche, high-performance additives has solidified its role in the US medical market, where precision and compliance are paramount. Ongoing developments include enhancing ESBO’s compatibility with recycled PVC for sustainable medical devices.

Key Innovations:

  • High-performance ESBO blends for sterile packaging

  • Strategic alliances with medical polymer producers

Read Full Report: Medical Grade Epoxidized Soybean Oil Market – View in Detailed Research Report


🌍 Outlook: The Future of Medical Grade Epoxidized Soybean Oil Is Safer and More Sustainable

The medical-grade ESBO market is experiencing steady evolution, with traditional applications in PVC stabilization paving the way for broader adoption in bio-based medical materials. While conventional plasticizers persist, the sector is channeling significant resources into phthalate-free alternatives, advanced purification technologies, and sustainable sourcing practices to address health and environmental concerns.

📈 Key Trends Shaping the Market:

  • Accelerated growth in Asia-Pacific due to medical manufacturing hubs

  • Regulatory mandates for non-toxic additives in medical devices by 2030

  • Digital tracking of supply chains for purity and sustainability certification

  • Collaborations between chemical producers and healthcare innovators for custom solutions

Market Trends Affecting Medical Grade Epoxidized Soybean Oil

  • Shift to Phthalate-Free Formulations — Regulatory pressures from FDA and EU are accelerating the replacement of traditional plasticizers in medical PVC, boosting ESBO demand. Companies like Arkema are leading with compliant products that maintain flexibility without health risks.

  • Sustainable Sourcing and Bio-Based Expansion — With growing emphasis on renewable materials, manufacturers are prioritizing GMO-free soybeans. CHS’s agricultural integration exemplifies how traceability enhances market appeal in eco-conscious healthcare sectors.

  • Advancements in Purification Technologies — Improved epoxidation processes are yielding higher oxirane content and lower impurities, essential for medical applications. Innovations from Galata Chemicals are setting new benchmarks for biocompatibility.

  • Growth in Medical Device Applications — Rising demand for flexible, sterilizable materials in tubing and packaging is driving ESBO use. BASF and Dow are expanding portfolios to support minimally invasive procedures and disposable devices.

  • Regional Market Dynamics — North America’s stringent standards contrast with Asia’s volume production; however, harmonization efforts are fostering global trade. Chinese firms like Xinjinlong are investing in export certifications to capture more share.

Read Full Report: Medical Grade Epoxidized Soybean Oil Market – View in Detailed Research Report
 

The companies listed above are not only stabilizing medical polymers—they’re pioneering the safer, greener future of healthcare materials.